An update on maternal medication-related embryopathies.

Prenatal Diagnosis
Willem Gheysen, Debra Kennedy

Abstract

There is a general perception that any exposure to medication during pregnancy poses a potential risk to the fetus. Most available data about teratogenic drugs is derived from animal studies, case reports, or cohort studies. As a result, counseling women and their partners about the safety of drugs during pregnancy can be difficult due to limited information about efficacy, pharmacokinetics, and teratogenicity of some drugs. However, this should always be done in the context of weighing up potential teratogenic risks with the perinatal risks of an untreated medical or psychiatric condition. Ideally, this counseling should occur prior to a planned pregnancy so that medications and treatment of chronic medical conditions can be optimized. It is important that clinicians providing antenatal care are able to confidently manage women including utilizing appropriate resources. This paper aims at reviewing a selected (non-exhaustive) list of the most commonly prescribed medications considered significant human teratogens and provides recommendations for pre-conception and antenatal counseling.

References

Apr 1, 1976·Drug Information Journal·M R Weinstein
Mar 1, 1975·American Journal of Diseases of Children·W L ShaulJ G Hall
May 1, 1990·The American Journal of Psychiatry·E V NunesF M Quitkin
May 1, 1990·American Journal of Obstetrics and Gynecology·M MamopoulosS Mantalenakis
Jun 1, 1990·The American Journal of Medicine·R D KozlowskiA M Segal
Sep 1, 1988·Teratology·W Lenz
Mar 15, 1986·Biochemical Pharmacology·M E Coakley, N A Brown
Oct 3, 1985·The New England Journal of Medicine·E J LammerI T Lott
Jan 1, 1965·Humangenetik·E Nowack
Oct 23, 1982·Lancet·E Robert, P Guibaud
Aug 1, 1994·Teratology·T H Shepard
Feb 1, 1994·Teratology·A E DonnenfeldG Koren
Jan 12, 1994·JAMA : the Journal of the American Medical Association·L S CohenM L Weiner
May 8, 1993·Lancet·Y VilleK H Nicolaides
Sep 1, 1995·Journal of Medical Genetics·J Clayton-Smith, D Donnai
Jun 16, 2001·Early Human Development·J WesselingB C Touwen
Aug 26, 2003·Expert Review of Anticancer Therapy·Philip J Johnson
Mar 23, 2005·Neurology·D F WyszynskiUNKNOWN Antiepileptic Drug Pregnancy Registry
May 3, 2005·Obstetrics and Gynecology·Nicole T YedlinskyPaul W Whitecar
Aug 16, 2005·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Yaron FinkelsteinGideon Koren
Sep 15, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J MorrowJ Craig
May 30, 2006·Thrombosis and Haemostasis·Christof SchaeferPaul Merlob
Jun 9, 2006·The New England Journal of Medicine·William O CooperWayne A Ray
Feb 28, 2008·Clinical Obstetrics and Gynecology·Barbra FisherJohn C Carey
Dec 24, 2008·Obstetrics and Gynecology·Catalin S Buhimschi, Carl P Weiner
Apr 17, 2009·The New England Journal of Medicine·Kimford J MeadorUNKNOWN NEAD Study Group
Jul 19, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Sarah Običan, Anthony R Scialli
Dec 29, 2011·Obstetrics and Gynecology International·Myla E MorettiGideon Koren
Feb 10, 2012·American Journal of Medical Genetics. Part a·Maria HoeltzenbeinChristof Schaefer
May 2, 2012·The Journal of Clinical Endocrinology and Metabolism·Ai YoshiharaKoichi Ito
Dec 5, 2012·Reproductive Toxicology·Catherine VauzelleElisabeth Elefant
Jan 3, 2013·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·L J SalomonG Yeo
Jan 26, 2013·BJOG : an International Journal of Obstetrics and Gynaecology·N BernardT Vial
Feb 26, 2013·Current HIV Research·Avinash K Shetty
Oct 24, 2013·The Journal of Clinical Endocrinology and Metabolism·Stine Linding AndersenPeter Laurberg
Feb 21, 2014·Drugs·Catherine M Brown, Vesna D Garovic
Jun 6, 2014·American Journal of Medical Genetics. Part a·April L DawsonUNKNOWN National Birth Defects Prevention Study

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.